Antisecretory effect of oral targeted therapies in advanced functioning neuroendocrine tumors (the ASSET-NET study) - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2022

Antisecretory effect of oral targeted therapies in advanced functioning neuroendocrine tumors (the ASSET-NET study)

Fichier non déposé

Dates et versions

hal-04490234 , version 1 (05-03-2024)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

  • HAL Id : hal-04490234 , version 1

Citer

Thomas Walter. Antisecretory effect of oral targeted therapies in advanced functioning neuroendocrine tumors (the ASSET-NET study). 19th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Mar 2022, Barcelona (ES), Spain. pp.186. ⟨hal-04490234⟩
12 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More